Abstract:Objective:To investigate the serum lipoprotein associated phospholipase A2 (LP-PLA2) and nonesterified fatty acid (NEFA) level of coronary heart disease (CHD) patients,and explore the relation between the indexes and pathologic characters of CHD and postoperative prognosis of percutaneous coronary intervention (PCI).Method:According to the results of coronary angiography,the total 589 experimental subjects come from department of cardiovascular medicine were divided into four groups:189 for control subjects,117 for single-vessel disease group,126 for double-vessel disease group and 157 for multi-vessel disease group.The blood samples were collected from the venous blood of the elbow of every patients.In the meanwhile,the blood samples of 166 patients who underwent PCI surgery were collected before the surgery,6 hours after,12 hours after,24 hours after and 48 hours after the surgery,and the level of serum LP-PLA2 and NEFAlevel were detected by Automatic biochemical analyzer.The differences in serum PLP-PLA2 and NAFE level were compared between different groups of patients and patients with PCI.Results:Compared with the group of control(209.34±87.32U/L),the serum level of LP-PLA2 in the group of single-vessel disease (351.77±103.26U/L) and the group of double-vessel disease (409.14±196.34U/L) and the group of multi-vessel disease (823.65 ± 369.94 U/L) are significantly higher(P＜0.01),and the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.The serum level of NEFA in the group of multi-vessel disease(0.92±0.49mmol/L)and the group of double-vessel disease (0.56±0.13mmol/L)and the group of single-vessel disease (1.22±0.8mmol/L) are significantly higher then the group of control subjects(0.23±0.07mmol/L)(P＜0.01).And the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.In addition,compared with the control subjects,the serum LP-PLA2 level after the PCI surgery 6 hours (644.64±361.34U/L vs 286.12±188.32U/L,P＜0.01) is significantly higher before the surgery,and after 12 hours of the surgery(452.57±245.56U/L),and 24 hours of the surgery (385.23±132.47U/ L) and 48 hours of the surgery (325.78±144.97U/L),are continue to decrease,which is statistically significant difference compared with each other (P＜0.01).There is no significant difference of the serum level of NEFA before and after the PCI operation(P＞0.05).Conclusion:The serum levels of LP-PLA2 and NEFA are closely associated with endothelial dysfunction andvascular endothelial function and arterial wall which have important clinical significance in assessment of the lesion severity of coronary arter in CHD patients.

Plasma lipoprotein phospholipase A2 and free fatty acids in patients with ischemic stroke

Low cholesterol level in erythrocyte membranes and high lipoperoxides level in erythrocytes may be potential main risk factors inducing cerebral hemorrhagic stroke in human

Relationship Between Cerebral Ischemia and Serum Level of Lipoprotein(a) in Old People with Chronic Atrial Fibrillation

Plasma Lipoprotein-Associated Phospholipase A2 Level and Its Clinical Significance in Patients with Stroke

Analysis on correlation between serum Lp-PLA2 level with ischemic stroke occurrence and prognosis in patients with hypertension

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A2 in Ischemic Stroke

The relationship of plasma Lp-PLA2 level with the stability of carotid artery atherosclerotic plaque and the severity of neurological impairment in patients with acute ischemic stroke

Comparison of serum Lp-PLA2 levels in ischemic stroke patients with H-type hypertension or non-H-type hypertension

Identification of Serum Biomarkers of Ischemic Stroke in a Hypertensive Population Based on Metabolomics and Lipidomics

Synergetic Effect of Lipoprotein(a) and Lipoprotein-Associated Phospholipase A2 on Functional Outcomes in Patients with Ischemic Stroke

Screening of Phospholipids in Plasma of Large-Artery Atherosclerotic and Cardioembolic Stroke Patients With Hydrophilic Interaction Chromatography-Mass Spectrometry

The association between circulating fatty acids and stroke in hypertensive patients

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke

Comparative study of plasma lipoprotein(a)concentration in different subtype of stroke

Lp(a) Lipoprotein and Plasminogen Activity in Patients with Different Etiology of Ischemic Stroke

Lipidomic analysis of plasma in patients with lacunar infarction using normal-phase/reversed-phase two-dimensional liquid chromatography–quadrupole time-of-flight mass spectrometry

[Level of Plasma Lysophosphatidic Acid in Patients with Cerebral Ischemic Attack, a Preliminary Study].

The relationship between pulse pressure with plasma PCSK9 and interleukin-6 among patients with acute ischemic stroke and dyslipidemia

The Study of the Relation between Serum Lipoprotein Associated Phospholipase A2 or Non-esterified Fatty Acid and Pathologic Characters of Coronary Artery in CHD Patients

Low Plasma Proportion of Omega 3-Polyunsaturated Fatty Acids Predicts Poor Outcome in Acute Non-Cardiogenic Ischemic Stroke Patients

Predictive value of lipoprotein-associated phospholipaseA2 to progressive ischemic stroke caused by large artery atherosclerosis